Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.

NCT03536806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation, Paroxysmal

Interventions

DRUG: Saline 0.9%
DRUG: Canrenone

Sponsor

National Institute of Cardiology, Warsaw, Poland